TABLE 1.

The therapies of the patients in case group.

Pts	Dementia drugs followed at home (previous hospitalization)	Need to increase therapy during hospitalization (0: not, 1: yes)	Need to add antipsychotic therapy during hospitalization (0: not, 1:yes)	Need to add benzodiazepine therapy during hospitalization (0: not, 1:yes)	Need to add opioids during hospitalization (0:not,1:yes)	Need to add other neuro/psychiatric drugs during hospitalization
1	//	0	0	0	0	No
2	Selective serotonin reuptake inhibitors	0	1	1	0	No
3	Antiepileptic drug	0	0	0	0	No
4	Benzodiazepine, antipsychotic drug	0	0	0	0	No
5	//	0	0	0	0	No
6	NMDA receptor antagonist, antipsychotic drug	0	0	0	0	No
7	Dopaminergic drug	0	0	0	0	No
8	Antipsychotic, gabapentin	0	0	0	0	No
9	Dopaminergic drug	1	1	0	0	No
10	Benzodiazepin	1	1	1	0	Antiepileptic drug (valproate)
11	//	0	0	1	0	No
12	//	0	1	0	0	Nr
13	//	1	0	0	0	No
14	Memantine	1	1	0	0	Nr
15	Lithium, antipsychotic drug	1	0	0	0	No
16	Antipsychotic drug, dopaminergic drug	0	0	1	0	No
17	//	1	0	1	0	No
18	//	1	0	1	0	No
19	//	1	0	1	0	No
20	//	0	0	1	0	No
21	//	0	0	1	0	Nr
22	Memantine	0	0	0	0	Nr
23	//	1	1	1	0	No

Pts, patients number; //, no treatment required at home; Nr, not reported; NMDA, N-Methyl-D-aspartate.